FASN and hepatocellular carcinoma: Recent research uncovered that cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase, concomitant targeting de novo lipogenesis and cholesterol biosynthesis are highly detrimental for the growth of human HCC cells (Che et al., 2019)